BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Scott Weiner to join panel at 2nd Annual Global Healthcare Investing Conference
News | 04. 30. 2008
